At KIC Ventures, our investment ethos is built upon a tripartite foundation: Team, Technology, and Traction. This approach not only enhances our existing strategy but also elevates our commitment to being at the forefront of outpatient spine surgery technology investments.
Analysts project substantial growth in sales of spinal surgery implants, instruments, pharmaceuticals, and novel treatments for chronic back pain, indicating a significant market opportunity to address the $250 billion annual economic cost of chronic back pain, aligning returns with societal impact. 1.The Market: The market for minimally invasive spine surgery is large and growing. 2.The Environment: A fundamental transition from inpatient to outpatient surgery is underway. 3.The Future: Motion and disc replacement are becoming increasingly favored over fixation and fusion.
Our Visionary Founders Since 2000, Have Been Investing and Leading the Future of Outpatient Spine Surgery Technologies. When You Join Us, Together We Will Build Upon A Legacy That Has Been Transforming Spine Surgery Since We Sold The MANTIS Percutaneous Pedicle Screw System to Stryker (Fortune 500 Company) For A 100x Return On Investment.
Why We Succeed
Our enduring success is rooted in a strategic approach that combines the astute deployment of founder capital with the valuable partnerships we forge with private investors, including many physicians and patients. This collaborative investment model amplifies our financial reach and integrates 360° diverse insights, enriching our portfolio with a well-rounded perspective